Table IV.
Gene | Cancer | Subtype | Case no. | Change expression | P-value (cancer/normal) | t-test (cancer/normal) | Fold change (cancer/normal) | % Gene ranking | Database reference |
---|---|---|---|---|---|---|---|---|---|
ASCL3 | Breast | Invasive ductal breast carcinoma | 30 | ↑ | 0.002 | 3.33 | 2.26 | 220 (top 2%) | (94) |
Kidney | Renal oncocytoma | 92 | ↓ | 5.15E-16 | −14.47 | −1.60 | 340 (top 3%) | (95) | |
Clear cell renal cell carcinoma | 20 | ↓ | 2.48E-4 | −4.66 | −3.08 | 1,143 (top 10%) | (95) | ||
Cervical | Cervical cancer | 84 | ↓ | 1.24E-9 | −8.49 | −1.65 | 96 (top 1%) | (96) | |
Bladder | Superficial bladder cancer | 60 | ↓ | 1.16E-7 | −6.62 | −1.63 | 274 (top 3%) | (75) | |
Lymphoma | Anaplastic large-cell lymphoma | 60 | ↓ | 1.58E-5 | −8.87 | −1.96 | 1,547 (top 8%) | (97) | |
Melanoma | Skin basal cell carcinoma | 87 | ↓ | 0.007 | −2.74 | −1.80 | 1,915 (top 10%) | (80) |